<p>Michael Thomas Henderson, Chief Executive Officer of Apogee Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Apogee Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-120758), on December 12, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

APOG

<p>Michael Thomas Henderson, CEO of Apogee Therapeutics Inc., reported the sale of common shares of the company. The information was published via EDGAR by the U.S. Securities and Exchange Commission on December 12, 2025. This news brief was generated by Public Technologies using AI and is for informational purposes only.</p>

Apogee Therapeutics CEO Michael Henderson Reports Sale of Common Shares